THP-00103
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for THP-00103, covering 2025-09-12 to 2025-09-12. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension [Phase 3]